3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
fludarabine phosphate
2
fludarabine
2
blinatumomab
2
Radiotherapy
2
Cyclophosphamide
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
talquetamab
1
obinutuzumab
1
Trastuzumab
1
Monatide (IMS 3015)
1
Maintenance
1
HMPL-013
1
Cetuximab
1
Blood Specimen Collection
1
Biological Assay
1
Ado-Trastuzumab Emtansine
1
AP 1903 reagent
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.